ECHO BIOTECH

ECHO BIOTECH (Beijing) Co., Ltd. is an innovative high-tech company dedicated to the development and clinical transformation of exosome technology. ECHO BIOTECH combines more than a decade of basic exosome research with molecular biology, cell biology, and bioinformatics to establish an exosome research and transformation platform. It has established collaborations with over 200 key hospitals in China, co-published more than 100 papers, involved over 20 types of samples, and processed over 10,000 samples. The company has received several rounds of financing amounting to hundreds of millions of RMB. It has participated in drafting expert consensus on exosomes and co-organized the "Exosome Grand Lecture Series" (with over 50 expert lectures conducted) with the Chinese Society for Extracellular Vesicles. The company has been recognized as a "Postdoctoral Research Station," "Specialized, Refined, Unique, and Innovative SME in Beijing," "National High-Tech Enterprise," "Zhongguancun High-Tech Enterprise," and "Zhongguancun Golden Seed Enterprise." The company's business is divided into two segments: one provides leading life science research services based on proprietary platforms, including a rich product line centered around the Exoomics® exosome omics platform for high-throughput multi-omics solutions and the ModiExo® engineered exosome platform for fundamental research solutions, continuously launching efficient exosome research tools tailored to customer needs; the other leverages its proprietary engineered exosome platform, Echosome®, to empower exosome-based innovative drug development. It has built a 3,000-square-meter GMP pilot production facility for exosomes and established a mature exosome production process and quality characterization system, offering CRO services such as the design and development of engineered exosome vectors and PCC development for engineered exosome drugs, as well as CDMO services for engineered exosomes. The company aims to empower clinical research and accelerate clinical transformation by providing systematic exosome research and transformation solutions, becoming a trusted partner for exosome research and transformation.